Quarter Financials
Crinetics Pharmaceuticals, Inc. (CRNX)
$21.96
-0.14 (-0.63%)
Income Statement
Balance Sheet
Cash Flow
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
Net Income | -45 | -42 | -42 | -35 | -31 | -28 | -26 | -23 |
Dividend Paid | - | - | - | - | - | - | - | - |
Retained Earnings | -439 | -394 | -352 | -310 | -275 | -244 | -217 | -191 |
---|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
Capital Expenditure | -0 | -1 | -1 | -0 | -0 | -0 | -0 | -0 |
Net PPE | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 |
---|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
New Purchases | -3 | - | -21 | -102 | -55 | -193 | -49 | -34 |
Intangible and Goodwill | - | - | - | - | - | - | - | - |
---|